BIOMAT Database Logo BIOMAT Database Logo

Keratosis pilaris-like eruption secondary to nilotinib in a child. 2020

Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Department of Dermatology, University Hospital of Pontevedra, Pontevedra (Galicia), Spain.

Nilotinib is a new multitargeted tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia when intolerance or recurrence to imatinib occurs. We report the case of a 14-year-old patient being treated with nilotinib who developed a keratosis pilaris-like eruption. This cutaneous adverse effect is a rare but increasingly reported side effect of this therapy.

UI MeSH Term Description Entries
D007644 Darier Disease An autosomal dominantly inherited skin disorder characterized by warty malodorous papules that coalesce into plaques. It is caused by mutations in the ATP2A2 gene encoding SERCA2 protein, one of the SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. The condition is similar, clinically and histologically, to BENIGN FAMILIAL PEMPHIGUS, another autosomal dominant skin disorder. Both diseases have defective calcium pumps (CALCIUM-TRANSPORTING ATPASES) and unstable desmosomal adhesion junctions (DESMOSOMES) between KERATINOCYTES. Acrokeratosis Verruciformis of Hopf,Darier-White Disease,Keratosis Follicularis,Acantholytic Dyskeratotic Epidermal Nevi,Acantholytic Dyskeratotic Epidermal Nevus,Acrokeratosis Verruciformis,Darier's Disease,Hopf Disease,Darier White Disease,Darier-White Diseases,Dariers Disease,Disease, Darier,Disease, Darier's,Disease, Darier-White,Disease, Hopf,Diseases, Darier-White,Diseases, Hopf,Hopf Acrokeratosis Verruciformis,Hopf Diseases,Verruciformis, Acrokeratosis
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005138 Eyebrows Curved rows of HAIR located on the upper edges of the eye sockets. Eyebrow
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000015 Abnormalities, Multiple Congenital abnormalities that affect more than one organ or body structure. Multiple Abnormalities
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016044 Fusion Proteins, bcr-abl Translation products of a fusion gene derived from CHROMOSOMAL TRANSLOCATION of C-ABL GENES to the genetic locus of the breakpoint cluster region gene on chromosome 22. Several different variants of the bcr-abl fusion proteins occur depending upon the precise location of the chromosomal breakpoint. These variants can be associated with distinct subtypes of leukemias such as PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; and NEUTROPHILIC LEUKEMIA, CHRONIC. Oncogene Protein p190(bcr-abl),Oncogene Protein p210(bcr-abl),bcr-abl Fusion Protein,bcr-abl Fusion Proteins,Bcr-Abl Tyrosine Kinase,Oncogene Protein p185(bcr-abl),Oncogene Protein p230(bcr-abl),p185(bcr-abl) Fusion Proteins,p190(bcr-abl) Fusion Proteins,p210(bcr-abl) Fusion Proteins,p230(bcr-abl) Fusion Proteins,Bcr Abl Tyrosine Kinase,Fusion Protein, bcr-abl,Fusion Proteins, bcr abl,Kinase, Bcr-Abl Tyrosine,Protein, bcr-abl Fusion,Tyrosine Kinase, Bcr-Abl,bcr abl Fusion Protein,bcr abl Fusion Proteins
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Keratosis pilaris-like eruption induced by nilotinib.
December 2021, Italian journal of dermatology and venereology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Widespread keratosis pilaris-like eruption in an immunocompromised child.
April 2019, JAAD case reports,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Nilotinib-Induced Keratosis Pilaris.
January 2016, Case reports in dermatology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
A case of vemurafenib-induced keratosis pilaris-like eruption.
April 2012, Dermatology online journal,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Generalized keratosis pilaris-like eruptions in a chronic myelogenous leukemia patient treated with nilotinib.
September 2016, The Journal of dermatology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Keratosis pilaris-like eruption observed during the experimental PLX 4032 studies.
December 2012, Journal of the American Academy of Dermatology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Nilotinib-induced generalized keratosis pilaris: Report of a rare case.
January 2021, Indian journal of pharmacology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Not just acne or keratosis pilaris-like eruption: A case of trichodysplasia-associated polyomavirus in a child with lymphoma.
August 2022, Pediatric blood & cancer,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Keratosis pilaris-like eruptions in a child following COVID-19 vaccination.
November 2023, International journal of dermatology,
Marcos Oro-Ayude, and Marta Feito, and Lucía Quintana-Castanedo, and Maria Jose Beato-Merino, and Raúl De Lucas
Nilotinib Induced Keratosis Pilaris in a Female with Chronic Myeloid Leukemia.
April 2024, Dermatology practical & conceptual,
Copied contents to your clipboard!